Homozygous variants in WDR83OS lead to a neurodevelopmental disorder with hypercholanemia

Scott Barish(Baylor College of Medicine), Davut Pehli̇van(Baylor College of Medicine), Øystein L. Holla(Telemark Hospital), Charlotte von der Lippe(Telemark Hospital), Marta Biderman Waberski(National Institutes of Health), Giovanni Zifarelli(Centogene (Germany)), Dana Marafi(Kuwait University), Sheng‐Jia Lin(Oklahoma Medical Research Foundation), Kristian Tveten(Telemark Hospital), Daniel G. Calame, Jawid M. Fatih(Baylor College of Medicine), Ilka Huber(Sørlandet Hospital Arendal), Paria Najarzadeh Torbati, Abdulrahman Alswaid(King Abdulaziz Medical City), Aurélien Trimouille(Hôpital Pellegrin), Øyvind L. Busk(Telemark Hospital), Javad Akhondian(Mashhad University of Medical Sciences), Ehsan Ghayoor Karimiani(St George's, University of London), Reza Shervin Badv(Children's Medical Center), Fatemeh Eghbal, Peter Bauer(Bioinova (Czechia)), Henry Houlden(Queen Mary University of London), Fowzan S. Alkuraya(Alfaisal University), Cassidy Petree(Oklahoma Medical Research Foundation), Alper Gezdirici, Tadahiro Mitani(Baylor College of Medicine), Reza Maroofian(National Hospital for Neurology and Neurosurgery), Kevin Huang(Oklahoma Medical Research Foundation), James R. Lupski(Baylor College of Medicine), Sami Wali(Riyadh Armed Forces Hospital), Mehran Beiraghi Toosi(Mashhad University of Medical Sciences), Ayat Al Safar(King Fahd Hospital of the University), Jennifer E. Posey(Baylor College of Medicine), Hamoud Alhebby(Riyadh Armed Forces Hospital), Gaurav K. Varshney(Oklahoma Medical Research Foundation)
The American Journal of Human Genetics
October 28, 2024
Cited by 2


Related Papers